API
![Ole mama maualuga ole potassium (R)-[(3-ethoxy-1-methyl-3-oxoprop-1-enyl)amino]phenylacetate ile tau lelei](https://ecdn6.globalso.com/upload/p/689/image_product/2024-04/661cf240b167b43209.png)
Tufuga mama maualuga CAS 1197-18-8 Tranexamic Acid
Tranexamic acid, e taʻua foi o le tranexamic acid, o se mea faʻapipiʻi gaosia o le lysine faʻatasi ma se fausaga tutusa ma tyrosine. Faʻamaonia e faʻataʻitaʻiga faʻataʻitaʻiga, e talafeagai mo ituaiga uma o paʻu ma e mafai ona aveese le pigmentation, paʻepaʻe, ma faʻamalamalamaina vaega, e pei o: pigmentation pe a uma le la, paʻu pogisa (chloasma, freckles, senile lentils, ma isi), paʻu maaleale, Acne ma fulafula, tausiga pe a maeʻa le laser, togafitiga moli faʻamalosi, ma isi. O le mea lea, o le tranexamic acid e mafai ona fautuaina mo le faʻaaogaina i mea faʻalelei e pei o kulimi, lotion, essences, lotions, ma mata ufimata.
Tranexamic acid o se vailaʻau faʻamaʻi amino acid antifibrinolytic faʻatauvaʻa e mafai ona faʻatauvaʻaina le fusifusia o le lysine i le fibrin i le plasmin, ma faʻafefe ai le lysis o fibrin clots ma gaosia ai le hemostasis. E masani ona faʻaaogaina ile falemaʻi. Mo ituaiga eseese o le toto e mafua mai i le hyperfibrinolysis.
Tranexamic acid Talosaga
1. Tranexamic acid o se vailaʻau faʻamaʻi-fibrinolytic, e mafai ona togafitia le tele o le maʻi ma le faʻamaʻi toto ma maua ai le hemostasis.
2.Tranexamic acid e mafai ona faʻaitiitia ai le gaosiga o le melanin: E mafai ona tauva tuusaʻo ma tyrosine i sela, faʻalavelaveina le aʻafiaga o le tyrosine metabolism, ma faʻaitiitia le gaosiga o le melanin.
3. Taofi le angiogenesis: E mafai ona tauva tuusao ma tyrosine i sela, taofia le catalytic aafiaga o tyrosine metabolism, ma taofia angiogenesis paʻu. O lenei mea e mafai ona faʻaitiitia ai le aofaʻi o vaʻa toto i totonu ma tafatafa o faʻamaʻi chloasma, faʻaitiitia le tupu mai o faʻamaʻi, ma faʻaitiitia ai le faʻaauau pea o le chloasma.
4.Tranexamic acid e mafai ona faʻaitiitia le faʻaalia o cytokines pro-inflammatory ma chemokines e faʻaaogaina ai aʻafiaga faʻamaʻi, lea e mafai ona puipuia lelei ai le tupu mai o faʻamaʻi ma faʻaitiitia ai le faʻavaeina o siama.
5. Tranexamic acid ei ai Anti-matua ma anti-photoaging meatotino. E faʻaleleia ai le faʻaogaina o le hyaluronic acid e ala i le faʻateleina o le numera o sela epidermal, faʻaitiitia le faʻaleagaina o le matrix extracellular i totonu o le dermis e ala i le polokaina o le plasmin, ma e mafai ona faʻaitiitia le maualuga o nisi mea faʻamaʻi i totonu o le toto e faʻaleleia ai le matua masani o le paʻu. Faʻaleleia le faʻataʻitaʻiga o le UVB e ala i le faʻateleina o le biogenesis mitochondrial, faʻatonutonuina o le hormone secretion e ala i le faʻateleina o le faʻaalia o le estrogen receptors i luga o le mast cell, ma le faʻaleleia o le UVA-induced photoaging.
Tranexamic acid Fa'amatalaga
Hebei WeiBang Biotechnology Co., Ltd
| Igoa Oloa | Tranexamic acid | CAS Nu | 1197-18-8 |
| Aso Gaosiga | 2023/12/01 | Lipoti Aso | 2023/12/01 |
| Tele | 10,000KG | Aso Su'ega | 2023/12/01 |
| VaegaNu | WB20231201 | Ola fa'asa | 2 tausaga |
| Su'ega Mea | Fa'amatalaga | ||
| Fa'aaliga | Pa'u tioata pa'epa'e | ||
| Fa'ailoaga | MA | ||
| Ma'imau ile fa'amago | ≤0.50% | ||
| pH | 7.0-8.0 | ||
| Su'ega | ≥99.0 | ||
| Lefulefu sulphated | ≤0.10% | ||
| Mea fa'atatau | Le mama A: ≤0.10% | ||
| Le mama B: ≤0.20% | |||
| So'o se isi mea leaga: ≤0.10% | |||
| O isi mea leaga uma: ≤0.20% | |||
| Klorida | ≤140ppm | ||
| Faitauga atoa o ipu | ≤1000cfu/g | ||
| Faafefete & limu | ≤100cfu/g | ||
| Pb | ≤10mg/kg | ||
| E pei o | ≤2mg/kg | ||
| Hg | ≤1mg/kg | ||
| Cd | ≤5mg/kg | ||
| Fa'ai'uga | Agavaa | ||